Trial intelligence / Profile preview

Fospropofol vs propofol for prevention of postoperative delirium in elderly gastrointestinal tumor surgery

ChiCTR2600118397Phase 4Not yet recruiting

Sponsor
The Fourth Hospital of Hebei Medical University
Start
Feb 2026
Modality
Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in gastrointestinal neoplasia comparing Fospropofol disodium arm with Propofol arm (2 arms). Primary endpoint: Postoperative delirium incidence. Planned start Feb 2026; status: not yet recruiting.

02

Drugs

fospropofol disodiumpropofol
03

Conditions

gastrointestinal neoplasia

Beyond the preview

Go deeper on ChiCTR2600118397.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2600118397.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call